Sign up
CGEM

Cullinan Oncology LLC (NASDAQ: CGEM)

Healthcare · Biotechnology

$9.01−0.26 (−2.86%)

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. CGEM fell 2.86% in the Nov 18 session to $9.01, which is 60.7% below its 52-week high of $22.95. Short interest is 16.26% of float with a 0.41% borrow fee. Five active firms cover the stock as of Nov 18, 2026; five active firms with targets average $36.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationBroadly in line with peers

P/S 25.9× vs peer median 13.9×

MomentumNeutral

RSI (14) 30.6 (overbought above 70, oversold below 30) · as of Nov 17, 2026

TrendBelow both averages

$9.28 vs $15.37 and $15.79 · as of Nov 17, 2026

Short interest16.3% of float

FINRA settlement Oct 30, 2026

CGEM price chart

Price $9.01 · As of Nov 18, 2026, 3:59 PM ET

Open full chart →
Nov 17, 2026O $9.45H $9.45L $8.47C $9.28Vol 1.63M

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 17, 2026 ET
Open$15.75
High$23.19
Low$8.47
Close$9.28
Volume125,958,038
Plotted bars128

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $15.75 · High $15.87 · Low $14.86 · Close $14.87 · Volume 1,941,017
  2. May 19, 2026 ET · Open $14.82 · High $14.82 · Low $13.34 · Close $14.18 · Volume 1,177,474
  3. May 20, 2026 ET · Open $14.30 · High $15.00 · Low $14.09 · Close $14.33 · Volume 988,508
  4. May 21, 2026 ET · Open $14.28 · High $14.43 · Low $13.81 · Close $13.98 · Volume 705,601
  5. May 22, 2026 ET · Open $14.00 · High $14.20 · Low $13.70 · Close $13.84 · Volume 471,167
  6. May 26, 2026 ET · Open $14.15 · High $15.52 · Low $14.00 · Close $15.46 · Volume 964,780
  7. May 27, 2026 ET · Open $15.63 · High $16.68 · Low $15.35 · Close $15.52 · Volume 1,344,995
  8. May 28, 2026 ET · Open $15.30 · High $15.75 · Low $14.84 · Close $15.36 · Volume 793,006
  9. May 29, 2026 ET · Open $15.19 · High $16.72 · Low $15.00 · Close $16.44 · Volume 1,877,763
  10. Jun 1, 2026 ET · Open $16.39 · High $16.60 · Low $15.90 · Close $16.21 · Volume 988,545
  11. Jun 2, 2026 ET · Open $15.89 · High $16.08 · Low $15.24 · Close $15.34 · Volume 1,290,378
  12. Jun 3, 2026 ET · Open $15.41 · High $15.50 · Low $15.01 · Close $15.21 · Volume 909,035
  13. Jun 4, 2026 ET · Open $15.21 · High $15.84 · Low $14.33 · Close $14.43 · Volume 984,147
  14. Jun 5, 2026 ET · Open $14.36 · High $14.47 · Low $13.47 · Close $13.51 · Volume 753,844
  15. Jun 8, 2026 ET · Open $13.72 · High $14.25 · Low $12.40 · Close $13.28 · Volume 1,740,673
  16. Jun 9, 2026 ET · Open $13.37 · High $13.75 · Low $12.46 · Close $13.18 · Volume 1,392,141
  17. Jun 10, 2026 ET · Open $13.14 · High $13.95 · Low $11.68 · Close $12.05 · Volume 2,102,370
  18. Jun 11, 2026 ET · Open $12.20 · High $13.29 · Low $11.97 · Close $12.98 · Volume 1,216,281
  19. Jun 12, 2026 ET · Open $13.07 · High $13.74 · Low $12.79 · Close $13.70 · Volume 1,318,279
  20. Jun 15, 2026 ET · Open $13.94 · High $14.50 · Low $13.52 · Close $13.61 · Volume 1,790,104
  21. Jun 16, 2026 ET · Open $13.70 · High $13.81 · Low $13.17 · Close $13.55 · Volume 1,062,328
  22. Jun 17, 2026 ET · Open $13.64 · High $15.25 · Low $13.63 · Close $14.44 · Volume 1,527,526
  23. Jun 18, 2026 ET · Open $14.80 · High $15.56 · Low $14.34 · Close $15.03 · Volume 3,117,265
  24. Jun 22, 2026 ET · Open $15.27 · High $17.40 · Low $15.26 · Close $17.30 · Volume 1,497,017
  25. Jun 23, 2026 ET · Open $16.80 · High $17.98 · Low $16.56 · Close $17.75 · Volume 1,960,284
  26. Jun 24, 2026 ET · Open $17.92 · High $18.76 · Low $17.61 · Close $17.65 · Volume 1,443,137
  27. Jun 25, 2026 ET · Open $17.51 · High $18.66 · Low $17.51 · Close $18.48 · Volume 1,306,755
  28. Jun 26, 2026 ET · Open $18.43 · High $19.43 · Low $17.90 · Close $18.40 · Volume 2,725,250
  29. Jun 29, 2026 ET · Open $18.41 · High $18.87 · Low $17.86 · Close $18.42 · Volume 990,605
  30. Jun 30, 2026 ET · Open $18.62 · High $18.82 · Low $18.19 · Close $18.21 · Volume 625,623
  31. Jul 1, 2026 ET · Open $18.06 · High $18.47 · Low $17.27 · Close $17.28 · Volume 748,115
  32. Jul 2, 2026 ET · Open $17.43 · High $18.10 · Low $17.19 · Close $17.63 · Volume 1,074,820
  33. Jul 6, 2026 ET · Open $17.53 · High $18.20 · Low $17.35 · Close $17.81 · Volume 771,769
  34. Jul 7, 2026 ET · Open $18.00 · High $18.55 · Low $17.54 · Close $18.16 · Volume 715,223
  35. Jul 8, 2026 ET · Open $17.86 · High $18.50 · Low $17.72 · Close $18.43 · Volume 618,635
  36. Jul 9, 2026 ET · Open $18.50 · High $18.78 · Low $18.09 · Close $18.38 · Volume 448,129
  37. Jul 10, 2026 ET · Open $18.20 · High $18.33 · Low $17.27 · Close $18.13 · Volume 684,715
  38. Jul 13, 2026 ET · Open $17.76 · High $18.20 · Low $17.29 · Close $17.87 · Volume 651,881
  39. Jul 14, 2026 ET · Open $17.90 · High $18.40 · Low $17.75 · Close $17.77 · Volume 636,865
  40. Jul 15, 2026 ET · Open $17.77 · High $18.05 · Low $17.30 · Close $17.83 · Volume 505,152
  41. Jul 16, 2026 ET · Open $17.62 · High $17.84 · Low $16.38 · Close $16.41 · Volume 842,967
  42. Jul 17, 2026 ET · Open $16.06 · High $17.89 · Low $16.00 · Close $17.69 · Volume 594,761
  43. Jul 20, 2026 ET · Open $17.76 · High $18.38 · Low $17.48 · Close $17.50 · Volume 472,339
  44. Jul 21, 2026 ET · Open $17.49 · High $18.20 · Low $17.49 · Close $18.06 · Volume 428,047
  45. Jul 22, 2026 ET · Open $17.96 · High $18.23 · Low $17.63 · Close $17.65 · Volume 494,335
  46. Jul 23, 2026 ET · Open $17.48 · High $17.70 · Low $17.14 · Close $17.28 · Volume 368,588
  47. Jul 24, 2026 ET · Open $17.40 · High $17.56 · Low $17.06 · Close $17.10 · Volume 316,656
  48. Jul 27, 2026 ET · Open $17.45 · High $17.99 · Low $17.13 · Close $17.43 · Volume 530,606
  49. Jul 28, 2026 ET · Open $17.62 · High $17.92 · Low $16.87 · Close $17.47 · Volume 572,144
  50. Jul 29, 2026 ET · Open $17.65 · High $17.98 · Low $16.62 · Close $17.21 · Volume 544,507
  51. Jul 30, 2026 ET · Open $17.35 · High $17.79 · Low $17.14 · Close $17.52 · Volume 489,149
  52. Jul 31, 2026 ET · Open $17.52 · High $17.52 · Low $16.14 · Close $16.50 · Volume 839,670
  53. Aug 3, 2026 ET · Open $16.50 · High $16.71 · Low $16.02 · Close $16.25 · Volume 386,709
  54. Aug 4, 2026 ET · Open $16.38 · High $17.88 · Low $16.38 · Close $17.55 · Volume 664,292
  55. Aug 5, 2026 ET · Open $17.65 · High $17.95 · Low $17.19 · Close $17.61 · Volume 465,624
  56. Aug 6, 2026 ET · Open $17.67 · High $17.99 · Low $17.06 · Close $17.95 · Volume 595,357
  57. Aug 7, 2026 ET · Open $18.14 · High $18.43 · Low $17.39 · Close $17.73 · Volume 361,755
  58. Aug 10, 2026 ET · Open $17.44 · High $18.33 · Low $17.30 · Close $18.28 · Volume 663,852
  59. Aug 11, 2026 ET · Open $18.76 · High $19.82 · Low $18.24 · Close $19.63 · Volume 808,168
  60. Aug 12, 2026 ET · Open $19.61 · High $19.94 · Low $19.39 · Close $19.60 · Volume 675,991
  61. Aug 13, 2026 ET · Open $20.72 · High $21.00 · Low $18.78 · Close $19.64 · Volume 1,802,496
  62. Aug 14, 2026 ET · Open $19.31 · High $20.37 · Low $18.58 · Close $20.34 · Volume 565,875
  63. Aug 17, 2026 ET · Open $20.02 · High $21.22 · Low $19.90 · Close $20.59 · Volume 894,686
  64. Aug 18, 2026 ET · Open $20.23 · High $21.20 · Low $19.99 · Close $20.84 · Volume 595,220
  65. Aug 19, 2026 ET · Open $21.48 · High $22.54 · Low $21.22 · Close $22.52 · Volume 707,192
  66. Aug 20, 2026 ET · Open $22.14 · High $22.25 · Low $21.02 · Close $21.38 · Volume 902,534
  67. Aug 21, 2026 ET · Open $21.72 · High $22.11 · Low $21.40 · Close $21.68 · Volume 758,223
  68. Aug 24, 2026 ET · Open $21.62 · High $22.37 · Low $21.16 · Close $21.82 · Volume 617,367
  69. Aug 25, 2026 ET · Open $22.16 · High $23.06 · Low $22.16 · Close $22.95 · Volume 519,255
  70. Aug 26, 2026 ET · Open $22.66 · High $23.19 · Low $22.42 · Close $22.85 · Volume 683,468
  71. Aug 27, 2026 ET · Open $22.55 · High $22.96 · Low $22.19 · Close $22.60 · Volume 471,914
  72. Aug 28, 2026 ET · Open $22.60 · High $22.88 · Low $21.57 · Close $21.70 · Volume 630,088
  73. Aug 31, 2026 ET · Open $21.50 · High $22.23 · Low $21.34 · Close $22.07 · Volume 682,984
  74. Sep 1, 2026 ET · Open $21.80 · High $22.07 · Low $21.55 · Close $21.79 · Volume 546,141
  75. Sep 2, 2026 ET · Open $21.88 · High $22.79 · Low $21.75 · Close $22.33 · Volume 769,692
  76. Sep 3, 2026 ET · Open $22.39 · High $22.68 · Low $21.65 · Close $22.16 · Volume 524,124
  77. Sep 4, 2026 ET · Open $21.88 · High $22.30 · Low $21.77 · Close $22.09 · Volume 562,485
  78. Sep 8, 2026 ET · Open $21.61 · High $22.41 · Low $21.28 · Close $21.69 · Volume 953,740
  79. Sep 9, 2026 ET · Open $21.30 · High $21.80 · Low $21.08 · Close $21.31 · Volume 1,278,698
  80. Sep 10, 2026 ET · Open $20.99 · High $21.22 · Low $20.50 · Close $21.00 · Volume 805,668
  81. Sep 11, 2026 ET · Open $21.16 · High $21.34 · Low $20.10 · Close $20.59 · Volume 1,090,836
  82. Sep 14, 2026 ET · Open $18.55 · High $20.93 · Low $18.51 · Close $20.40 · Volume 1,418,334
  83. Sep 15, 2026 ET · Open $20.38 · High $20.71 · Low $19.64 · Close $20.54 · Volume 1,060,746
  84. Sep 16, 2026 ET · Open $20.50 · High $20.84 · Low $20.20 · Close $20.63 · Volume 825,812
  85. Sep 17, 2026 ET · Open $21.06 · High $21.58 · Low $20.81 · Close $21.36 · Volume 756,836
  86. Sep 18, 2026 ET · Open $21.38 · High $21.45 · Low $20.63 · Close $21.08 · Volume 3,251,021
  87. Sep 21, 2026 ET · Open $21.45 · High $21.79 · Low $20.98 · Close $21.35 · Volume 763,871
  88. Sep 22, 2026 ET · Open $21.44 · High $21.88 · Low $21.27 · Close $21.67 · Volume 831,811
  89. Sep 23, 2026 ET · Open $21.67 · High $21.67 · Low $16.78 · Close $16.87 · Volume 2,595,561
  90. Sep 24, 2026 ET · Open $16.60 · High $16.88 · Low $14.80 · Close $15.44 · Volume 2,728,966
  91. Sep 25, 2026 ET · Open $15.62 · High $15.62 · Low $14.67 · Close $14.81 · Volume 1,715,524
  92. Sep 28, 2026 ET · Open $14.71 · High $15.19 · Low $14.20 · Close $14.95 · Volume 1,109,220
  93. Sep 29, 2026 ET · Open $15.00 · High $15.44 · Low $14.68 · Close $15.23 · Volume 1,244,423
  94. Sep 30, 2026 ET · Open $15.39 · High $15.78 · Low $14.96 · Close $15.35 · Volume 1,067,167
  95. Oct 1, 2026 ET · Open $15.22 · High $15.39 · Low $14.49 · Close $14.53 · Volume 911,808
  96. Oct 2, 2026 ET · Open $14.76 · High $15.56 · Low $14.59 · Close $15.51 · Volume 1,162,135
  97. Oct 5, 2026 ET · Open $15.59 · High $16.55 · Low $15.13 · Close $16.04 · Volume 1,082,965
  98. Oct 6, 2026 ET · Open $17.24 · High $17.70 · Low $16.06 · Close $16.25 · Volume 2,017,233
  99. Oct 7, 2026 ET · Open $15.95 · High $16.46 · Low $15.47 · Close $15.63 · Volume 808,185
  100. Oct 8, 2026 ET · Open $15.60 · High $15.71 · Low $14.81 · Close $15.46 · Volume 1,137,458
  101. Oct 9, 2026 ET · Open $15.41 · High $15.95 · Low $15.24 · Close $15.53 · Volume 567,527
  102. Oct 12, 2026 ET · Open $15.45 · High $15.64 · Low $14.88 · Close $14.95 · Volume 372,441
  103. Oct 13, 2026 ET · Open $14.86 · High $14.93 · Low $14.08 · Close $14.10 · Volume 590,350
  104. Oct 14, 2026 ET · Open $13.81 · High $14.18 · Low $13.44 · Close $13.64 · Volume 903,554
  105. Oct 15, 2026 ET · Open $13.62 · High $14.18 · Low $13.46 · Close $14.00 · Volume 972,108
  106. Oct 16, 2026 ET · Open $13.91 · High $13.91 · Low $12.81 · Close $12.93 · Volume 1,123,301
  107. Oct 19, 2026 ET · Open $13.02 · High $14.00 · Low $12.77 · Close $13.98 · Volume 862,461
  108. Oct 20, 2026 ET · Open $13.92 · High $14.92 · Low $13.85 · Close $14.83 · Volume 694,016
  109. Oct 21, 2026 ET · Open $14.92 · High $15.26 · Low $14.64 · Close $14.89 · Volume 690,976
  110. Oct 22, 2026 ET · Open $14.82 · High $15.32 · Low $14.64 · Close $14.92 · Volume 392,651
  111. Oct 23, 2026 ET · Open $14.95 · High $14.95 · Low $13.86 · Close $14.37 · Volume 485,204
  112. Oct 26, 2026 ET · Open $14.71 · High $14.87 · Low $14.39 · Close $14.54 · Volume 438,575
  113. Oct 27, 2026 ET · Open $14.66 · High $14.98 · Low $14.28 · Close $14.84 · Volume 488,228
  114. Oct 28, 2026 ET · Open $14.93 · High $15.62 · Low $14.72 · Close $15.56 · Volume 594,319
  115. Oct 29, 2026 ET · Open $15.60 · High $16.19 · Low $15.35 · Close $15.45 · Volume 460,064
  116. Oct 30, 2026 ET · Open $15.38 · High $15.72 · Low $14.70 · Close $15.03 · Volume 389,414
  117. Nov 2, 2026 ET · Open $15.13 · High $15.35 · Low $14.63 · Close $14.93 · Volume 730,766
  118. Nov 3, 2026 ET · Open $15.04 · High $16.20 · Low $14.98 · Close $15.75 · Volume 788,705
  119. Nov 4, 2026 ET · Open $15.99 · High $16.29 · Low $11.92 · Close $12.49 · Volume 2,203,294
  120. Nov 5, 2026 ET · Open $12.36 · High $12.48 · Low $10.77 · Close $10.80 · Volume 1,789,228
  121. Nov 6, 2026 ET · Open $11.09 · High $11.77 · Low $10.69 · Close $11.31 · Volume 755,709
  122. Nov 9, 2026 ET · Open $11.40 · High $12.41 · Low $10.80 · Close $11.73 · Volume 1,035,285
  123. Nov 10, 2026 ET · Open $11.71 · High $12.04 · Low $10.95 · Close $11.23 · Volume 810,429
  124. Nov 11, 2026 ET · Open $11.34 · High $11.68 · Low $11.15 · Close $11.35 · Volume 985,830
  125. Nov 12, 2026 ET · Open $11.04 · High $11.12 · Low $10.11 · Close $10.19 · Volume 1,135,512
  126. Nov 13, 2026 ET · Open $10.19 · High $10.35 · Low $9.75 · Close $10.28 · Volume 1,376,933
  127. Nov 16, 2026 ET · Open $10.11 · High $10.28 · Low $9.46 · Close $9.50 · Volume 866,741
  128. Nov 17, 2026 ET · Open $9.45 · High $9.45 · Low $8.47 · Close $9.28 · Volume 1,625,936

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 17, 2026, 8:39 PM ET

Initial 6M price range summary
Range6M
First close$14.87
Last close$9.28
High$23.19
Low$8.47
Volume125,958,038
Open
$9.17Nov 18, 2026 session
Previous close
$9.28Nov 17, 2026 close
Day range
$8.81 – $9.51Nov 18, 2026 session
52-week range
$8.45 – $22.95Through Nov 18, 2026
Volume
1.06MNov 18, 2026 session
Average volume (30 calendar days, 22 sessions)
890.92KThrough Nov 18, 2026
Market cap$667.39M
P/E (TTM)9.0
Forward P/E—
EPS (TTM)eps split basis unknown —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)0.06

Price history

CGEM · nasdaq · USD

Last completed session: Nov 17, 2026

Split-adjusted · volume in shares

Missing session: Nov 18, 2026

November 2026 · 12 completed sessions
DateOpenHighLowCloseChangeVolume
9.459.458.479.275−0.225−2.368421%1,625,936
Open 9.45High 9.45Low 8.47
10.1110.27529.469.50−0.78−7.587549%866,741
Open 10.11High 10.2752Low 9.46
10.1910.3459.7510.28+0.09+0.883219%1,376,933
Open 10.19High 10.345Low 9.75
11.0411.1210.10510.19−1.16−10.220264%1,135,512
Open 11.04High 11.12Low 10.105
11.3411.67511.1511.35+0.12+1.068566%985,830
Open 11.34High 11.675Low 11.15
11.7112.0410.9511.23−0.50−4.262575%810,429
Open 11.71High 12.04Low 10.95
11.4012.4110.79511.73+0.42+3.713528%1,035,285
Open 11.40High 12.41Low 10.795
Event only——————
11.0911.7710.690111.31+0.51+4.722222%755,709
Open 11.09High 11.77Low 10.6901
12.3612.47510.7710.80−1.69−13.530825%1,789,228
Open 12.36High 12.475Low 10.77
15.9916.28511.9212.49−3.26−20.698413%2,203,294
Open 15.99High 16.285Low 11.92
15.0416.2014.97515.75+0.82+5.492297%788,705
Open 15.04High 16.20Low 14.975
15.1315.34514.6314.93−0.10−0.665336%730,766
Open 15.13High 15.345Low 14.63

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $10.19−10.22%

    Trading volume was 1.4 times the 30-day average, with 1.14M shares traded.

  2. $10.80−13.53%

    Trading volume was 2.2 times the 30-day average, with 1.79M shares traded.

  3. $12.49−20.70%

    Trading volume was 2.9 times the 30-day average, with 2.2M shares traded.

Options flow

— · Options flow not available

Q Score

18/100Poor

Latest available: Nov 13, 2026 · updates irregularly

Each axis is a 0 to 100 percentile rank among equities

Liquidity48Short26Squeeze89Trend14Momentum18Valuation47Stability23
What each one means
  • Liquidity48

    Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.

  • Short26

    Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.

  • Squeeze89

    Higher scores reflect a higher published Squeeze score within equity peers.

  • Trend14

    Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.

  • Momentum18

    Higher scores reflect stronger 63- and 126-session total returns within equity peers.

  • Valuation47

    Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.

  • Stability23

    Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.

How the Q Score works →

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide33Calm Tide—
Squeeze50Watch—
How the scores work →

How CGEM compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Points of caution

  1. Three-month return was -58.8%, with only 16% of 559 peers reporting a lower value.Peer median −31.6% · As of Nov 16, 2026
  2. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Broadly in line with peers

  • Price/sales25.86×13.85×

    Higher than 60% of 407 peers

  • Forward P/E6.74×14.97×

    Not ranked: only 193 of 592 peers report it

  • Price/book2.35×2.58×

    Higher than 47% of 551 peers

Profitability

Profitability metrics are mixed versus peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin0.0%0.0%

    Higher than 26% of 442 peers

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−55.5%−68.0%

    Higher than 58% of 554 peers

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year0.0%0.0%

    Higher than 32% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Balance sheet metrics are higher than most peers.

  • Current ratio7.434.99

    Higher than 65% of 498 peers

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are mixed versus peers.

  • 1-year return+8.5%−29.8%

    Higher than 71% of 522 peers

  • 6-month return−34.6%−24.0%

    Higher than 38% of 547 peers

  • 3-month return−58.8%−31.6%

    Higher than 16% of 559 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
5Buy
0Neutral
0Sell
0Strong Sell

Based on 5 active firms as of Nov 18, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$30.00
Average$36.00
High$42.00

As of Nov 18, 2026 across 5 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 1 insider sales and 0 purchases. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider sellMichaelson JenniferSell$49.4KForm 4
Insider sellMichaelson JenniferSell$172.6KForm 4
Insider sellMichaelson JenniferSell$607.8KForm 4
Insider sellMichaelson JenniferSell$142.6KForm 4
Insider sellMichaelson JenniferSell$3.1KForm 4
Insider sellMichaelson JenniferSell$113.9KForm 4
Insider sellMichaelson JenniferSell$125.4KForm 4
Insider sellMichaelson JenniferSell$25.2KForm 4
Insider sellMichaelson JenniferSell$52.1KForm 4
Insider sellMichaelson JenniferSell$24.5KForm 4
All smart-money activity →

News and press releases

All CGEM news →

Company profile

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed

CEO
Mr. Nadim Ahmed M.S.
Headquarters
Cambridge, MA, United States
Employees
109
IPO date
Jan 8, 2021
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.